High Intensity Focused Ultrasound (HIFU) in Digestive Diseases: An Overview of Clinical Applications for Liver and Pancreatic Tumors

This publication has 43 references indexed in Scilit:

• Irreversible Electroporation Ablation (IRE) of Unresectable Soft Tissue Tumors: Learning Curve Evaluation in the First 150 Patients Treated
  PLOS ONE, 2013
• Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma
  Annals of Surgery, 2013
• Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
  The Lancet Oncology, 2013
• Tolerance of High‐Intensity Focused Ultrasound Ablation in Patients with Hepatocellular Carcinoma
  World Journal of Surgery, 2012
• Follow-Up of High-Intensity Focused Ultrasound Treatment for Patients with Hepatocellular Carcinoma
  Ultrasound in Medicine & Biology, 2011
• Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
  Journal of Clinical Oncology, 2011
• Concurrent Chemotherapy and Pulsed High-Intensity Focused Ultrasound Therapy for the Treatment of Unresectable Pancreatic Cancer: Initial Experiences
  Korean Journal of Radiology, 2011
• High-Intensity Focused Ultrasound Ablation: Effective and Safe Therapy for Solid Tumors in Difficult Locations
  American Journal of Roentgenology, 2010
• Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma
  European Journal of Cancer, 2010
• Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma
  Journal of Gastroenterology and Hepatology, 2007